Drug Type Small molecule drug |
Synonyms Hdac inhibitor cxd101, Hdac-in-4, AZD 9468 + [2] |
Target |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H29N5O |
InChIKeyJHDZMASHNBKTPS-UHFFFAOYSA-N |
CAS Registry934828-12-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peripheral T-Cell Lymphoma | Phase 2 | GB | 25 Apr 2023 | |
Metastatic Microsatellite Stable Colorectal Carcinoma | Phase 2 | GB | 22 May 2018 | |
Colorectal Cancer | Phase 2 | GB | - | |
Hepatocellular Carcinoma | Phase 1 | GB | - |
Phase 1 | 39 | knkljwnfhy(iiaqscofjk) = vtgkxpldwk lrcscqvouj (hiprfdvieh ) View more | Positive | 07 Jun 2017 | |||
knkljwnfhy(iiaqscofjk) = euwrawejlx lrcscqvouj (hiprfdvieh ) View more |